UNSPSC 51181604: Thyroid-stimulating hormone or thyrotropin or thyrotropin alfa

This classification denotes a pituitary agent with the molecular formula C975H1513N267O304S26, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AVX3D5A4LM, more generally known as thyrotropin alfa. European Medicines Agency schedules thyrotropin alfa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12610MIG. The term THYROTROPIN ALFA is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 12 no. 2 1999, list 40.

UNSPSC 51181604 Thyroid-stimulating hormone or thyrotropin or thyrotropin alfa, a Commodity code, covers the procurement of thyroid-stimulating hormone (TSH) and thyrotropin alfa pharmaceutical products by state and local health agencies, hospital systems, and public health departments. State and local governments procure these pharmaceuticals primarily through hospital formularies, public health clinics, and centralized pharmaceutical purchasing programs for diagnostic and therapeutic use in patient care settings. The code encompasses both natural and recombinant forms of thyrotropin, which are used in thyroid testing and thyroid cancer treatment protocols.

The source materials contain no recent state and local contract opportunities tagged to this code, making it difficult to characterize the active issuing-body mix, geographic concentration, or current market activity for thyroid-stimulating hormone procurement at the state and local level. Without posted RFPs, RFQs, or ITB notices, no representative recent solicitations are available to illustrate current buying patterns, dollar volumes, or responding vendor activity under this Commodity code.